Teva Pharmaceutical Industries Ltd. (TEVA) vs Viatris Inc. (VTRS)
- Teva Pharmaceutical Industries Ltd. TEVA 41.52 +1.00%
- Viatris Inc. VTRS 18.66 +2.41%
Teva Pharmaceutical Industries Ltd. and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Teva Pharmaceutical Industries Ltd. is the larger, with a market value of $47.9B against $20.9B — 2.3× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; Teva Pharmaceutical Industries Ltd. trades at 65.9×. Viatris Inc. grew revenue faster over the last twelve months: 4.40% against 4.13%. Teva Pharmaceutical Industries Ltd. has the higher net margin (4.08% vs −2.79%) and the higher return on invested capital (4.58% vs −0.20%). Across the 20 metrics below, Viatris Inc. leads on 11 and Teva Pharmaceutical Industries Ltd. on 9.
Valuation
Profitability
| Metric | TEVA | VTRS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 52.46% | 34.83% | 53.94% |
| Operating margin | 8.77% | (0.59%) | 0.00% |
| Net margin | 4.08% | (2.79%) | 0.00% |
| Free cash flow margin | 8.09% | 12.83% | 0.00% |
| Return on equity | 9.69% | (2.75%) | (0.40%) |
| Return on assets | 1.77% | (1.12%) | (3.32%) |
| Return on invested capital | 4.58% | (0.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack